Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0369820040340040283
Jorunal of Korean Pharmaceutical Sciences
2004 Volume.34 No. 4 p.283 ~ p.288
Pharmacokinetic Interaction between Nifedipine and Quercetin in Rabbits
ÇÑÈ¿°æ/Han HK
ÀÌÀϱÇ/ÃÖÁؽÄ/Lee IK/Choi JS
Abstract
The pharmacokinetics of nifedipine was studied after oral coadministration of nifedipine (5 mg/kg) with quercetin (1.5, 7.5, 15 and 30 mg/kg, respectively) and 0.5 h or 3days pretreatment with quercetin (1.5 and 7.5mg/kg) in rabbits. Pretreatment of quercetin significantly (p<0.05, at 0.5 h; p<0.01, at 3 days) increased the plasma concentration of nifedipine, but not significant in coadministraiton. The area under the plasma concentration-time curve (AUC) and the peak concentration (Cmax) of nifedipine pretreated with quercetin were increased significantly (p<0.05, at 0.5 h; p<0.01, at 3 days) compared to the control. By coadministration of quercetin, only 7.5 mg/kg of quercetin increased plasma AUC and Cmax of nifedipine significantly (p<0.05) compared to the control. Plasma AUC of intravenous nifedipine (1 mg/kg) is 4235¡¾1192ng/ml?hr. Pretreatment of quercetin significantly (p<0.05, at 0.5 h; p<0.01, at 3 days) increased the absolute bioavailability (AB%) of nifedipine to 23.9-29.2% compared to the control (17.8%). Coadministration of quercetin showed no significant effect on the AB% of nifedipine except for 7.5 mg/kg. It is suggested that quercetin alters disposition of nifedipine by inhibition of P-glycoprotein efflux pump and its first-pass metabolism. The dosage of nifedipine should be adjusted when it is administered chronically with quercetin in a clinical situation.
KEYWORD
Nifedipine, Quercetin, Pharmacokinetics, Bioavailability, P-glycoprotein, First-pass metabolism
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)